financetom
Business
financetom
/
Business
/
Some UBS capital rules should be softened, lawmakers tell Swiss government
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Some UBS capital rules should be softened, lawmakers tell Swiss government
Nov 4, 2025 8:36 AM

ZURICH, Nov 4 (Reuters) - Capital requirements for UBS

should not exceed those in other major financial

centres, a Swiss parliamentary committee said on Tuesday,

increasing pressure on the government to ease part of the

proposed rules that do not require lawmakers' approval.

The remarks by the lower chamber's influential economic

affairs and taxation committee follow parliamentary hearings

with top UBS executives, leaders of the Swiss National Bank and

the head of financial market regulator FINMA.

"The tightening of regulations must ensure a competitive

cost-benefit ratio for the Swiss capital regime," the committee

said in a letter to the government.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump's fees on Chinese ships will hurt US companies, maritime executives to tell hearing
Trump's fees on Chinese ships will hurt US companies, maritime executives to tell hearing
Mar 24, 2025
* Hearing on proposed USTR port fee scheduled for Monday * Proposed fee on Chinese vessels will hurt US operators, ports * Taxpayer investments in seaborne-trade at risk of being wasted By Lisa Baertlein LOS ANGELES, March 24 (Reuters) - President Donald Trump's plan to revitalize the U.S. shipbuilding industry is likely to backfire because it relies on proposed fees...
BYD's 2024 Revenue Tops Tesla, Estimates
BYD's 2024 Revenue Tops Tesla, Estimates
Mar 24, 2025
10:27 AM EDT, 03/24/2025 (MT Newswires) -- China's BYD reported 2024 operating revenue Monday of 777.10 billion Chinese renminbi ($107.20 billion), up from 602.32 billion renminbi in 2023 and beating Tesla's (TSLA) $97.69 billion revenue for the same year. Analysts polled by FactSet estimated BYD's 2024 revenue at 767.67 billion renminbi. BYD's 2024 net profit also increased to 40.25 billion...
Novo Nordisk Expands Wegovy Savings Program
Novo Nordisk Expands Wegovy Savings Program
Mar 24, 2025
10:24 AM EDT, 03/24/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Monday it will now allow cash-paying patients access to Wegovy injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at local pharmacies for a reduced cost of $499 per month following updates to its Wegovy savings program. The $499-per-month offer for Wegovy was only...
Novo Nordisk Strikes Up to $2 Billion Licensing Deal for Chinese Firm's Obesity, Diabetes Drug Candidate
Novo Nordisk Strikes Up to $2 Billion Licensing Deal for Chinese Firm's Obesity, Diabetes Drug Candidate
Mar 24, 2025
10:26 AM EDT, 03/24/2025 (MT Newswires) -- Novo Nordisk ( NVO ) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. The product called UBT251 targets the receptors for glucagon-like peptide-1, or GLP-1, glucose-dependent insulinotropic polypeptide, or GIP, and glucagon. The drug is currently...
Copyright 2023-2026 - www.financetom.com All Rights Reserved